首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug metabolism and disposition

缩写:DRUG METAB DISPOS

ISSN:0090-9556

e-ISSN:1521-009X

IF/分区:4.0/Q1

文章目录 更多期刊信息

共收录本刊相关文章索引3840
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Katsuhiko Mizuno,Kenji Takeuchi,Ken Umehara et al. Katsuhiko Mizuno et al.
Vildagliptin (VG), a dipeptidyl peptidase-4 inhibitor, is used for treating type 2 diabetes. On rare occasions, VG causes liver injury as an adverse reaction. One case report suggested the involvement of immune responses in the hepatotoxici...
Hongwei Yao,Ruifeng Bai,Tianming Ren et al. Hongwei Yao et al.
Clopidogrel (Clop), a thienopyridine antiplatelet prodrug, is metabolized by cytochrome P450s (CYPs) to an active metabolite, Clop-AM, and hydrolyzed by carboxylesterase (CES)1 to the inactive Clop-acid. Patients with type 2 diabetes (T2DM)...
Donglu Zhang,Aimee Fourie-O&#x;Donohue,Peter S Dragovich et al. Donglu Zhang et al.
In cells, catalytic disulfide cleavage is an essential mechanism in protein folding and synthesis. However, detailed enzymatic catalytic mechanism relating cleavage of disulfide bonds in xenobiotics is not well understood. This study report...
Matthew D Harwood,Mian Zhang,Shriram M Pathak et al. Matthew D Harwood et al.
The aim of this study was to derive region-specific transporter expression data suitable for in vitro-to-in vivo extrapolation (IVIVE) within a physiologically based pharmacokinetic (PBPK) modeling framework. A meta-analysis was performed w...
Xiuli Li,Jingchao Sun,Zitao Guo et al. Xiuli Li et al.
Exp3174 is an active metabolite of losartan for the treatment of hypertension. Allisartan (ALS3) is a marketed ester prodrug of Exp3174 to reduce bioavailability variation of losartan in China. However, ALS3 exhibited a lower oral absorptio...
Yong Ma,Josefa Dela Cruz-Chuh,S Cyrus Khojasteh et al. Yong Ma et al.
Carfilzomib (CFZ) is a proteasome inhibitor used for oncology indications including treating multiple myeloma. CFZ is a potent cytotoxic agent with an IC50 value in the nanomolar range in various cancer cell lines and was considered as a po...
Péter Tátrai,Patrick Schweigler,Birk Poller et al. Péter Tátrai et al.
Preincubation of a drug transporter with its inhibitor in a cell-based assay may result in the apparent enhancement of the inhibitory potency. Currently, limited data are available on potentiation of transporter inhibition by preincubation ...
Jakub Hofman,Ales Sorf,Dimitrios Vagiannis et al. Jakub Hofman et al.
Alectinib is a tyrosine kinase inhibitor currently used as a first-line treatment of anaplastic lymphoma kinase-positive metastatic nonsmall cell lung cancer (NSCLC). In the present work, we investigated possible interactions of this novel ...
Andrea N Robinson,Bethelihem G Tebase,Sonia C Francone et al. Andrea N Robinson et al.
Although overexpression of multiple ATP-binding cassette transporters has been reported in clinical samples, few studies have examined how coexpression of multiple transporters affected resistance to chemotherapeutic drugs. We therefore exa...
Gabriela I Patilea-Vrana,Jashvant D Unadkat Gabriela I Patilea-Vrana
The prevalence of cannabis use and the concentrations of the psychoactive cannabinoid in cannabis, (-)-∆9-tetrahydrocannabinol (THC), are rising. Physiologically based pharmacokinetic modeling and simulations (PBPK M&S) can mechanistically...